Adolescent Medicine News

In a recent study, 98% of transgender adolescents who were prescribed gender-affirming hormone treatment after using pubertal blockers continued to use gender-affirming hormones in adulthood.

More than 3 million middle and high school students reported continuous tobacco use in 2022, according to findings published in MMWR.

Inpatient and outpatient volume increased for pediatric patients with an eating disorder following the onset of the COVID-19 pandemic, according to a study published in JAMA Pediatrics.

The decision to ban gender-affirming care for youth in Florida will cause “irrevocable harm,” ACP President Ryan D. Mire, MD, MACP, said in a press release.

Although the prevalence of e-cigarette use peaked in 2019, the age of initiation of nicotine continues to decrease, and the intensity of use rises annually, researchers reported in JAMA Network Open.

Daily e-cigarette use among teens “seemed to accelerate” after 2017, according to a new study in JAMA Network Open.

SAN DIEGO — Adolescents with obesity had a BMI reduction of 16.1% at 68 weeks with once-weekly subcutaneous semaglutide 2.4 mg plus lifestyle intervention, results similar to those seen with adults, according to top-line results presented at ObesityWeek 2022.

ANAHEIM, Calif. — In this video exclusive, Francesca Barrett, MD, MBA, discusses concerns with fertility preservation and posthumous use of assisted reproductive technologies for adolescents and young adults with poor cancer prognoses.

FDA enforcement actions have a “likely minimal” impact on the vaping industry since they target smaller retailers rather than larger e-cigarette brands or products, according to researchers.

Rates of follow-up after acute mental health service use in younger individuals were suboptimal, but improving involvement with outpatient mental health care providers may increase rates, per a new study published in Psychiatric Services.